Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA059569-05
Application #
2608098
Study Section
Pathology A Study Section (PTHA)
Program Officer
Johnson, George S
Project Start
1993-12-15
Project End
1998-05-31
Budget Start
1997-12-01
Budget End
1998-05-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost

  Institution

Name
University of Texas Sw Medical Center Dallas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390

  Publications

Gottstein, C; Wels, W; Ober, B et al. (2001) Generation and characterization of recombinant vascular targeting agents from hybridoma cell lines. Biotechniques 30:190-4, 196, 198 passim
Huang, X; Molema, G; King, S et al. (1997) Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 275:547-50
Derbyshire, E J; Yang, Y C; Li, S et al. (1996) Heparin-steroid conjugates lacking glucocorticoid or mineralocorticoid activities inhibit the proliferation of vascular endothelial cells. Biochim Biophys Acta 1310:86-96
Derbyshire, E J; Comin, G A; Yang, Y C et al. (1995) Anti-tumor and anti-angiogenic effects in mice of heparin conjugated to angiostatic steroids. Int J Cancer 63:694-701